138
Kardiyopulmoner Bypass ve Optimal Koşulları
Kaynaklar
1. Gibbon JH Jr. The development of the heart-lung apparatus.
Am J Surg 1978; 135:608-19
2. Hessel EA 2nd. A Brief History of Cardiopulmonary Bypass.
Semin Cardiothorac Vasc Anesth 2014; 18: 87-100
3. Lillehei CW, Cohen M, Warden HE, Varco RL. The direct-vision
intracardiac correction of congenital anomalies by controlled
cross circulation; results in thirty-two patients with ventricular
septal defects, tetralogy of Fallot, and atrioventricularis com-
munis defects. Surgery 1955; 38:11-29
4. Stephenson LW. History of cardiac surgery. In: Cohn LW, Car-
diac Surgery in the Adult, 3rd ed, The McGraw-Hill Companies,
Inc, New York, 2008:3-28
5. Hammon JW. Extracorporeal Circulation: A. Perfusion Sys-
tems, B. The Response of Humoral and Cellular. In: Cohn LW,
Cardiac Surgery in the Adult, 3rd ed, The McGraw-Hill Compa-
nies, Inc., New York, 2008: 349-414
6. Jones T and Elliott MJ. Perfusion techniques. In: Stark JF, de
Leval MR, Tsang VT. Surgery for Congenital Heart Defects, 3rd
ed, John Wiley and Sons, Ltd, England, 2006:167-186
7. Taketani S, Sawa Y, Massai T, Ichikawa H, Kagisaki K, Yama-
guchi T, Ohtake S, Matsuda H. A novel technique for cardiopul-
monary bypass using vacuum system for venous drainage with
pressure relief valve: an experimental study. Artif Organs 1998;
22:337
8. Leontyev S, Borger MA, Legare JF, Merk D, Hahn J, Seeburger
J, Lehmann S, Mohr FW. Iatrogenic type A aortic dissection du-
ring cardiac procedures: early and late outcome in 48 patients.
Eur J Cardiothorac Surg 2012; 41:641-6
9. Gaylor JDS. Membrane Oxygenators: Current Developments
in Design and Application. Journal of Biomedical Engineering
1988; 10:541-47
10. Groom RC, Stammers AH: Extracorporeal devices and rela-
ted technologies. In: Kaplan JA, Cardiac Anesthesia, 6th ed, WB
Saunders, Philadelphia, 2011; 888-992
11. Baufreton C, Intractor L, Jansen PGM, te Velthuis H, Le
Besnerais P, Vonk A, Farcet JP, Wildevuur CR, Loisance DY. Inf-
lammatory response to cardiopulmonary bypass using roller or
centrifugal pumps. Ann Thorac Surg 1999; 67:972-7
12. Mahmood S, Bilal H, Zaman M, Tang A. Is a fully hepa-
rin-bonded cardiopulmonary bypass circuit superior to a stan-
dard cardiopulmonary bypass circuit? Interact Cardiovasc Tho-
rac Surg 2012; 14: 406-14
13. Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H,
Coskun T, Kleesiek K, Koerfer R. Heparin-coated extracorporeal
circulation in combination with low dose systemic heparinizati-
on reduces early postoperative blood loss in cardiac surgery. J
Cardiovasc Surg (Torino) 2008; 49: 277-84
14. Tayama E, Hayashida N, Akasu K, Kosuga T, Fukunaga S,
Akashi H, Kawara T, Aoyagi S. Biocompatibility of heparin-coa-
ted extracorporeal bypass circuits: new heparin bonded bioline
system. Artif Organs. 2000; 24:618–23
15. Doenst T, Schlensak C, Beyersdorf F. Cardioplegia in pedi-
atric cardiac surgery: do we believe in magic? Ann Thorac Surg
2003; 75: 1668-77
16. Elliott MJ. Ultrafiltration and modified ultrafiltration in pedi-
atric open heart operations. Ann Thorac Surg 1993; 56: 1518-22
17. Davies MJ, Nguyen K, Gaynor JW, Elliott MJ. Modified ult-
rafiltration improves left ventricular systolic function in infants
after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998;
115: 361-9
18. Loor G, Rajeswaran J, Li L, Sabik JF 3rd, Blackstone EH, McC-
rae KR, Koch CG. The least of 3 evils: exposure to red blood cell
transfusion, anemia, or both? J Thorac Cardiovasc Surg 2013;
146: 1480-7
19. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger
MP, Groom RC, Forest RJ, Pieroni JW, Warren CS, Bogosian ME,
Krumholz CF, Clark C, Clough RA, Weldner PW, Lahey SJ, Lea-
vitt BJ, Marrin CA, Charlesworth DC, Marshall P, O’ConnorGT.
Lowest hematocrit on bypass and adverse outcomes associated
with coronary artery bypass grafting. Ann Thorac Surg 2001; 71:
769-76
20. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ,
Shah A. Adverse effects of low hematocrit during cardiopulmo-
nary bypass in the adult: should current practice be changed? J
Thorac Cardiovasc Surg 2003; 125: 1438-50
21. Mathew JP, Mackensen GB, Phillips-Bute B, Stafford-Smith
M, Podgoreanu MV, Grocott HP, Hill SE, Smith PK, Blumenthal
JA, Reves JG, Newman MF. Effects of extreme hemodilution du-
ring cardiac surgery on cognitive function in the elderly. Anest-
hesiology 2007; 107: 577-84
22. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C,
Dattilo KM, Djaiani G, Ivanov J, Karaski J, David TE. Hemodiluti-
on during cardiopulmonary bypass is an independent risk factor
for acute renal failure in adult cardiac surgery. J Thorac Cardio-
vasc Surg 2005; 129: 391-400
23. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engloran M,
Durham SJ, Shah A. Role of hemodilutional anemia and transfu-
139
Kalp ve Anestezi
sion during cardiopulmonary bypass in renal injury after coro-
nary revascularization: implications on operative outcomes. Crit
Care Med 2005; 33: 1749-56
24. Karkouti K, Djaiani G, Borger MA, Beattie WS, Fedorko L,
Wijeysundera D, Ivanov J, Karski J. Low hematocrit during car-
diopulmonary bypass is associated with increased risk of peri-
operative stroke in cardiac surgery. Ann Thorac Surg 2005; 80:
1381-7
25. Fransen E, Maessen J, Dentemer M, Senden N, Buurman W.
Impact of blood transfusion on inflammatory mediator release
in patients undergoing cardiac surgery. Chest 1999; 116: 1233-9
26. Murphy PJ, Connery C, Hicks GL, Blumberg N. Homologous
blood transfusion as a risk factor for postoperative infection af-
ter coronary artery bypass graft operations. J Thorac Cardiovasc
Surg 1992; 104: 1092-9
27. Ottino G, Paulis R, Pansini S. Major sternal wound infection
after open-heart surgery: a multi-varient analysis of risk factors
in 2579 consecutive operative procedures. Ann Thorac Surg
1987; 44: 173-9
28. Avgerinos DV, Debois W, Salemi A. Blood conservation stra-
tegies in cardiac surgery: more is better. Eur J Cardiothorac Surg
2014 Jan 30. [Epub ahead of print]
29. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengis-
tu A. Cardiopulmonary bypass priming using a high dose of a
balanced hydroxyethyl starch versus an albumin-based priming
strategy. Anesth Analg 2009; 109: 1752-62.
30. Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer
M, Alexander JL, Scoppettuolo LA, Pigula FA, Charpie JR, Ohye
RG, Gaies MG; SPECS Study Investigators.Tight glycemic cont-
rol versus standard care after pediatric cardiac surgery. N Engl J
Med 2012; 367: 1208-19
31. Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino
JA. Perioperative hyperglycemia is associated with postoperati-
ve neurocognitive disorders after cardiac surgery. Neuropsychi-
atr Dis Treat 2014; 10: 361-70
32. Despotis GJ, Joist JH. Anticoagulation and anticoagulation
reversal with cardiac surgery involving cardiopulmonary by-
pass: an update. J Cardiothorac Vasc Anesth 1999; 13 (4 Suppl
1): 18-29
33. Argueta-Morales IR, Olsen MC, DeCampli WM, Munro HM,
Felix DE. Alternative anticoagulation during cardiovascular pro-
cedures in pediatric patients with heparin-induced thrombocy-
topenia. J Extra Corpor Technol 2012; 44: 69-74
34. Caputo M, Dihmis WC, Bryan AJ, Suleiman MS, Angelini GD.
Warm blood hyperkalaemic reperfusion (hot shot) prevents
myocardial substrate derangement in patients undergoing co-
ronary artery bypass surgery. Eur J Cardiothorac Surg 1998; 13:
559-64
35. Murphy GS, Hessel EA 2nd, Groom RC. Optimal perfusion
during cardiopulmonary bypass: an evidence-based approach.
Anesth Analg 2009; 108: 1394-417
36. Suttner S, Piper SN, Kumle B, Lang K, Röhm KD, Isgro F,
Boldt J. The influence of allogeneic red blood cell transfusion
compared with 100% oxygen ventilation on systemic oxygen
transport and skeletal muscle oxygen tension after cardiac sur-
gery. Anesth Analg 2004; 99: 2-11
37. Boston US, Slater JM, Orszulak TA, Cook DJ.Hierarchy of
regional oxygen delivery during cardiopulmonary bypass. Ann
Thorac Surg 2001; 71:260-4
38. Lees MH, Herr RH, Hill JD, Morgan CL, Ochsner AJ 3rd, Tho-
mas C, Van Fleet DL. Distribution of systemic blood flow of the
rhesus monkey during cardiopulmonary bypass. J Thorac Cardi-
ovasc Surg 1971; 61:570-86
39. Kent B, Peirce EC II. Oxygen consumption during cardio-
pulmonary bypass in the uniformly cooled dog. J Appl Physiol
1974; 37:917-22
40. Joshi B, Brady K, Lee J, Easley B, Panigrahi R, Smielewski P,
Czosnyka M, Hogue CW Jr. Impaired autoregulation of cerebral
blood flow during rewarming from hypothermic cardiopulmo-
nary bypass and its potential association with stroke. Anesth
Analg 2010; 110: 321-8
41. Donmez A, Yurdakok O. Cardiopulmonary bypass in infants.
J Cardiothoracic Vasc Anesth 2014; 28:778-88
42. Sahu B, Chauhan S, Kiran U, Bisoi A, Lakshmy R, Selvaraj T,
Nehra A. Neurocognitive function in patients undergoing coro-
nary artery bypass graft surgery with cardiopulmonary bypass:
the effect of two different rewarming strategies. J Cardiothorac
Vasc Anesth 2009; 23:14-21
43. Kutsal A. Pediatrik kalp cerrahisinde kardiyopulmoner by-
pass ve miyokard koruması. In: Duran E. Kalp ve Damar Cerrahisi
Kitabı, Çapa Tıp Kitabevi, İstanbul, 2004; 251-61
44. Talor JJ, Undar A. Pediatric cardiopulmonary bypass: does
perfusion mode matter? World J Pediatr Congenit Heart Surg
2011; 2: 296-300
45. Abdul Aziz KA, Meduoye A. Is pH-stat or alpha-stat the best
technique to follow in patients undergoing deep hypothermic
circulatory arrest? Interact Cardiovasc Thorac Surg 2010; 10:
271-82
46. Newburger JW, Jonas RA, Wernovsky G, Wypij D, Hickey PR,
Kuban KC, Farrell DM, Holmes GL, Helmers SL, Constantinou J,
140
Kardiyopulmoner Bypass ve Optimal Koşulları
et al.A comparison of the perioperative neurologic effects of hy-
pothermic circulatory arrest versus low-flow cardiopulmonary
bypass in infant heart surgery. N Engl J Med 1993; 329: 1057-64
47. Zierer A, El-Sayed Ahmad A, Papadopoulos N, Moritz A,
Diegeler A, Urbanski PP. Selective antegrade cerebral perfusion
and mild (28°C-30°C) systemic hypothermic circulatory arrest
for aortic arch replacement: results from 1002 patients. J Tho-
rac Cardiovasc Surg 2012; 144: 1042-49
48. Algra SO, Schouten AN, van Oeveren W, van der Tweel I,
Schoof PH, Jansen NJ, Haas F. Neurological injury after neonatal
cardiac surgery: a randomized, controlled trial of 2 perfusion
techniques. Circulation 2014; 129: 224-33
49. Bechtel A, Huffmyer J. Anesthetic Management for Cardio-
pulmonary Bypass: Update for 2014. Semin Cardiothorac Vasc
Anesth 2014; 18: 101-16
50. Ak K, Isbir S, Tekeli A, Ergen A, Atalan N, Dogan S, Civelek A,
Arsan S. Presence of lipoprotein lipase S447X stop codon affe-
cts the magnitude of interleukin 8 release after cardiac surgery
with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007;
134: 477-83
51. Shann K, Melnitchouk S. Advances in Perfusion Techniqu-
es: Minimally Invasive Procedures. Semin Cardiothorac Vasc
Anesth 2014; 18:146-52
52. Shann KG, Likosky DS, Murkin JM, Baker RA, Baribeau YR,
DeFoe GR, Dickinson TA, Gardner TJ, Grocott HP, O’Connor GT,
Rosinski DJ, Sellke FW, Willcox TW. An evidence-based review
of the practice of cardiopulmonary bypass in adults: a focus
on neurologic injury, glycemic control, hemodilution, and the
inflammatory response. J Thorac Cardiovasc Surg 2006; 132:
283-90
53. Society of Thoracic Surgeons Blood Conservation Guideline
Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK,
Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR; So-
ciety of Cardiovascular Anesthesiologists Special Task Force on
Blood Transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith
M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative
blood transfusion and blood conservation in cardiac surgery:
the Society of Thoracic Surgeons and The Society of Cardiovas-
cular Anesthesiologists clinical practice guideline. Ann Thorac
Surg 2007; 83 (5 Suppl): S27-S86
Dostları ilə paylaş: |